Vascular Architects Aspire Covered Stent and 718 Delivery System
Prosthesis, Tracheal, Expandable. 510(k) K031641, from Vascular Architects, Inc. (San Jose, CA). Product code JCT, class 2.
As of Nov 22, 2026, K031641 is an FDA 510(k) held by Vascular Architects, Inc., substantially equivalent on Aug 1, 2003 after 66 days, with no recalls tied to it in FDA's recall database.
- Review time: 66 days
- Recalls: 0
The Vascular Architects aSpire® Covered Stent and 718™ Delivery System are indicated for use in the treatment of tracheobronhial strictures produced by malignant neoplasms.
- Aspire Covered Stent and Delivery CatheterK003173 · Vascular Architects, Inc. · Mar 13, 2001
- Vascular Architects Aspire Covered Stent and Controlled Expansion Delivery SystemK012544 · Vascular Architects, Inc. · Nov 15, 2001
- Modification To Vascular Architects Aspire Covered Stent and Contrilled Expansion Delivery SystemK030567 · Vascular Architects, Inc. · Mar 24, 2003
- Ultraflex™ Tracheobronchial Stent SystemK230269 · Boston Scientific Corporation · Jul 14, 2023
- Through the Scope Tracheal Stent SystemK220424 · Micro-Tech (Nanjing) Co., Ltd. · Jul 8, 2022
- Tracheal Stent System (Y-Shaped)K212403 · Micro-Tech (Nanjing) Co., Ltd. · Oct 30, 2021
- Tracheal Stent SystemK202204 · Micro-Tech (Nanjing) Co., Ltd. · Sep 1, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 27, 2003
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.3720
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files